Tissue Regenix Group plc (LON:TRX) is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a
The International Stock Exchange (TISE) had a strong first half to 2023, with revenue +7% to £5.2m and fully diluted EPS +17% to 83p, against a backdrop of subdued financial
Real Estate Credit Investments Ltd (LON:RECI) current discount to NAV (15%) suggests to us that some investors could be concerned that potential issues with commercial real estate (CRE) will dramatically
In our 15 March initiation, Pawnbroking royalty, with strong, profitable growth, we highlighted that H&T Group Plc (LON:HAT) core is pawnbroking and related retail services operations. The 8 August interim
Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Since its US launch
ICG Enterprise Trust plc (LON:ICGT) hosted an Investor Day on 13 June 2023. The key takeaways were i) a clear, defensive-growth investment strategy, targeting superior risk-adjusted returns over the long
International Biotechnology Trust plc (LON:IBT) was established in 1994 to provide institutional and retail investors with the opportunity to participate in global biotechnology and life science companies, from venture-stage early
The key takeaway from Apax Global Alpha Ltd (LON:APAX) 27 June Capital Markets Day (CMD) was that 84% of value creation comes from operational improvements that APAX makes in the
NB Private Equity Partners Ltd (LON:NBPE) private equity (PE) portfolio has co-investments, alongside 55 PE managers (GPs) in 90 high-secular-growth and downside-resilient private companies. PE provides access to a different
Our recent notes, in the main, have focused on why Real Estate Credit Investments Ltd (LON:RECI) should prove resilient in uncertain times, given its credit processes, high-quality security, low exposure
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
